The Cocaine Plant: From Ancient Use to Modern Synthesis

Dec.02.2022
The coca plant, also known as Erythroxylum coca, contains cocaine and has been used for medicinal and cultural purposes.

The leaves of the Erythroxylum coca Lam., commonly referred to as the coca tree or coca plant, have a tea-like scent and contain between 0.25% and 1.3% of a stimulating substance known as cocaine. While the production of cocaine has evolved to become a means of pest control, the exhilarating effects of the substance caught the attention of ancient Andean dwellers. For thousands of years, indigenous people have chewed coca leaves or brewed them to help ward off fatigue, hunger, and particularly altitude sickness, known as "soroche." Planting coca in the mountainous regions of South America has become a lucrative profession, with as many as four harvests per year. In Peru or Bolivia, coca leaf extract is added to beverages, candies, cookies, and toothpaste. On the other hand, pure cocaine extracted from the leaves has potent medical uses.


The synthesis of cocaine is a highly complex process that scientists have been studying for decades. This knowledge is not only valuable to the pharmaceutical industry, which can create structurally similar compounds, but also to biologists interested in understanding the evolution of natural insecticides in the plant world.


Until now, scientists at the Kunming Institute of Botany in China have only recently managed to understand the final crucial stage of cocaine biosynthesis, even reconstructing this process in a modified plant - tobacco (which synthesizes nicotine and also has insecticidal properties).


According to experts, although the cultivation of this tobacco is not more profitable than ordinary coca, similar modifications can be made to yeast or bacteria for pharmaceutical purposes.


Cocaine belongs to a group of organic molecules known as tropane alkaloids. Other alkaloids in this group include atropine and hyoscyamine, which are produced by the plant Atropa belladonna and have long been used in medicine for dilating pupils, paralyzing salivary glands during surgery, and relieving irregular heart rhythms.


In chemistry, cocaine and methamphetamine share many similarities and have recently been found to originate from the same precursor molecule called 4-(1-methyl-2-pyrrolidinyl)-3-oxobutyric acid (MPOA).


The structure differences between two molecules are small but significant. It has long been a mystery how coca plants convert MPOA into cocaine. Now, a pair of enzymes called EnCYP81AN15 and EnMT4 have been identified. While the synthesis process is not yet fully understood, scientists say that the known enzymes are capable of synthesizing it.


Chinese scientists have demonstrated the ability of tobacco plants, specifically Nicotiana benthamiana, to produce cocaine by introducing six genes involved in the production of the drug. These hybrid plants were able to utilize their own enzymes to fill the gaps in the synthesis process, resulting in the production of cocaine within the modified tobacco plants.


According to the author of the study, gaining an understanding of the synthetic process can lead to the creation of novel biologically active compounds, potentially allowing scientists to improve formulations and discover more effective compounds.


2FIRSTS will continue to report on this issue. Further updates will be available on the '2FIRSTS APP.' Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Smoore International Q1 Results: Enterprise-Focused Business Up 48.6% Year-on-Year, Proprietary E-Vapor Brand Business Up 14.3%
Smoore International Q1 Results: Enterprise-Focused Business Up 48.6% Year-on-Year, Proprietary E-Vapor Brand Business Up 14.3%
Smoore International reported its Q1 financial results, with revenue for the period reaching RMB3.856 billion, up 41.7% year-on-year, and net profit (profit for the period) totaling RMB262.5 million, up 36.6% year-on-year. Revenue from its enterprise-focused business was RMB3.2674 billion, representing a 48.6% increase from RMB2.1989 billion in the same period last year. Revenue from its proprietary brand business was RMB588.6 million, up 12.6% from RMB522.6 million a year earlier.
Apr.10 by 2FIRSTS.ai
STG UK refreshes XQS nicotine pouch packaging: new flavour indicators, hitting retail from March
STG UK refreshes XQS nicotine pouch packaging: new flavour indicators, hitting retail from March
Scandinavian Tobacco Group UK (STG UK) has announced a rebrand across its XQS nicotine pouch range. The updated packaging will be visible at retail from March, with the recommended retail price remaining £5.50. The new packs feature a bolder logo and glossy textures, retain nicotine strength indicators, and add a side flavour profile indicator to show the flavour type.
Feb.28 by 2FIRSTS.ai
FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements
FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements
FDA announced it will convene a Feb. 10, 2026 roundtable with small tobacco product manufacturers to gather feedback on PMTA submissions for ENDS products. The discussion will be viewable online, and a public docket is open for comments through March 12, 2026.
Feb.10 by 2FIRSTS.ai
Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance
Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance
Breeze Smoke and Glas, Inc. have separately requested White House review under Executive Order 12866 as the FDA advances draft guidance on flavored ENDS (RIN 0910-ZC78). The guidance aims to clarify evidentiary standards under the statutory “appropriate for the protection of public health” (APPH) framework. The parallel filings highlight industry concern over regulatory predictability, particularly as Glas’s PMTA review status has recently drawn market attention.
Special Report
Mar.03
BAT Japan Announces McLaren Collaboration “glo Hilo Plus” Limited-Edition Set, Priced at About USD 200
BAT Japan Announces McLaren Collaboration “glo Hilo Plus” Limited-Edition Set, Priced at About USD 200
British American Tobacco Japan (BAT Japan) announced a collaboration with McLaren Racing to launch the “glo Hilo Plus・McLaren Racing Inspired Limited-Edition Set.” Sales begin on March 3 via the glo Store Ginza and the official glo online store. Based on the “glo Hilo Plus,” the set includes a limited-edition device and dedicated accessories, priced at JPY 30,000 (about USD 200).
Mar.03 by 2FIRSTS.ai
KT&G Approves Plan to Establish Guatemala Branch as First Local Base in Central and South America
KT&G Approves Plan to Establish Guatemala Branch as First Local Base in Central and South America
KT&G has approved a plan to establish a branch in Guatemala, which will serve as its first local base in Central and South America. The company is currently preparing office space, staffing, and operating systems. KT&G said the branch is intended to secure a regional distribution base and will focus on local channel management and new sales channel expansion. Meanwhile, overseas cigarette revenue in 2025 exceeded the domestic share for the first time.
Mar.09 by 2FIRSTS.ai